)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Hikma Pharmaceuticals
Hikma Pharmaceuticals (HIK) investor relations material
Hikma Pharmaceuticals H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary26 Feb, 2026
Executive summary
Leadership transition focused on long-term growth, empowerment, and agility, with heavy investment in R&D, talent, and supply chain improvements.
Achieved 6% year-over-year core revenue growth to $3,349m and 3% increase in core operating profit to $741m for 2025.
Maintained strong EBITDA margins and consistent growth, outperforming competitors with a 25.5% core EBITDA margin and 16.0% ROIC.
Strategic focus on three divisions: Injectables, Rx (generics), and Branded, driving diversified growth across MENA, Europe, and North America.
Financial highlights
EBITDA margin stands at 25%–25.5%, ahead of competitors targeting 22%.
Core EBITDA rose 4% to $853m; core basic EPS up 2% to 228¢ year-over-year.
Rx division achieved 20% margins and strong EBITDA, with expectations for further improvement.
Branded segment growth accelerated to 7%-8% from previous 5%-6%.
$250 million share buyback approved for 2024.
Outlook and guidance
2025 and 2026 expected to be challenging for injectables due to reduced CMO contribution and delayed product launches.
2026 group revenue expected to grow 2–4%; core operating profit guided at $720–770m.
Growth acceleration anticipated from 2027 onward, driven by new product launches and expanded CMO capacity.
$5 billion revenue target for 2030 reaffirmed as achievable, with acceleration post-2026.
Injectable margins guided at 27%-28% for the next three years, down from previous 30%+ due to increased R&D and investment.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Hikma Pharmaceuticals earnings date
H1 20266 Aug, 2026
Hikma Pharmaceuticals
Next Hikma Pharmaceuticals earnings date
H1 20266 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company specializing in the development, manufacturing, and distribution of branded, generic, and injectable medicines. The company serves a wide range of therapeutic areas, including cardiovascular, oncology, pain management, and respiratory diseases. Hikma provides high-quality, affordable medications to hospitals, pharmacies, and wholesalers in global markets. The company is headquartered in London, United Kingdom, and its shares are listed on the LSE (London Stock Exchange).
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage